drug

Vortioxetine

MeSH D000078784
as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Alen Greš
3 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
small molecule

Indications

Trials

3
Cognitive Effects of Adjuvant Vortioxetine in Early Schizophrenia
NCT04895488Phase 2, Phase 3Unknown
Adjunctive Vortioxetine in Schizophrenia
NCT02357797Phase 4Unknown
Effect of Vortioxetine on Cognitive Symptoms in Patients With Schizophrenia
NCT04456777Early Phase 1Unknown

KOLs & investigators

2
Christoph U. Correll, MDKOL score 96
Benedicto Crespo Facorro, ProfessorKOL score 5

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
Alen Greš
company
trial
Cognitive Effects of Adjuvant Vortioxetine in Early Schizophrenia
PHASE2, PHASE3
trial
Adjunctive Vortioxetine in Schizophrenia
PHASE4
trial
Effect of Vortioxetine on Cognitive Symptoms in Patients With Schizophrenia
EARLY_PHASE1
trial
indication
Schizophrenia
indication
Cognitive Impairment With Primary Psychotic Disorder
indication
Schizophrenia
indication
Cognitive Deficit
indication
KOL
Christoph U. Correll, MD
KOL score 96
person
Benedicto Crespo Facorro, Professor
KOL score 5
person